Many say yesterday's announcement was primarily in response to public pressure over new generation melanoma drugs. Pharmac yesterday announced funding for Opdivo, an advanced melanoma drug in the same class as Keytruda.
To embed this content on your own webpage, cut and paste the following:
<iframe src="https://www.rnz.co.nz/audio/remote-player?id=201799541" width="100%" frameborder="0" height="62px"></iframe>
for easy access to all your favourite programmes